Sustained Benefits With TransCon PTH in Hypoparathyroidism

TOPLINE: Long-term treatment with TransCon parathyroid hormone (PTH), a replacement therapy for hypoparathyroidism, demonstrates sustained efficacy and safety in patients with hypoparathyroidism over 52 weeks, with 95% of participants able to discontinue conventional therapy. METHODOLOGY: Conventional therapy for hypoparathyroidism (active vitamin D and elemental calcium) alleviates symptoms of hypocalcemia, butContinue Reading

High-speed 3D bioprinter can fabricate structures that closely mimic diverse tissues in human body

The 3D bioprinter at the Collins BioMicrosystems Laboratory at the University of Melbourne. Credit: University of Melbourne Biomedical engineers from the University of Melbourne have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain tissueContinue Reading

Can the ACO Primary Care Flex Model help link physical and mental healthcare?

The connection between behavioral health and physical health is well-documented. Physical health is greatly affected by such behaviors as smoking, substance abuse, poor diet, lack of exercise, insufficient sleep and more. In addition, mental health issues and social determinants of health, such as lack of housing or transportation, language barriers,Continue Reading

Do GLP-1 Agonists Really Need to Be Stopped Before Endoscopy?

Meeting Coverage > ACG — Meta-analysis suggests 24-hour clear liquid diet works to avoid aspiration, even with GLP-1s by Tara Haelle, Contributing Writer, MedPage Today November 5, 2024 Continuing GLP-1 receptor agonist medications when undergoing an endoscopic procedure appeared safe in a meta-analysis. In pooled findings from nine studies, patientsContinue Reading